Droperidol Injection Market

This product is colorless or slightly yellow clear liquid. Used for schizophrenia and mania excitement. With anesthesia and sedative effects.COVID-19 has erupted in the world, and these drugs are in short supply.

Droperidol Injection Market contains market size and forecasts of Droperidol Injection in global, including the following market information:

Global Droperidol Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Droperidol Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Droperidol Injection companies in 2021 (%)

The global Droperidol Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2.5mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Droperidol Injection include Pfizer, American Regent, Phebra, Shagnhai Xudong Haipu Pharmaceutical, Beijing Yookon and Shandong Hualu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Droperidol Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Droperidol Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Droperidol Injection Market Segment Percentages, by Type, 2021 (%)

• 2.5mg/ml
• 5mg/2ml

Global Droperidol Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Droperidol Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Droperidol Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Droperidol Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Droperidol Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Droperidol Injection revenues share in global market, 2021 (%)
• Key companies Droperidol Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Droperidol Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• American Regent
• Phebra
• Shagnhai Xudong Haipu Pharmaceutical
• Beijing Yookon
• Shandong Hualu Pharmaceutical